Birmingham, West Midlands -- (SBWIRE) -- 12/10/2013 -- Value Penny Stocks issues special report on Hecla Mining Company (NYSE:HL), AK Steel Holding Corporation (NYSE:AKS), Novavax, Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals Inc (NASDAQ:MACK).
Hecla Mining Company (NYSE:HL) ended its recent business day with the gain of 2.86% and closed at the price of $2.88 after opening at $2.83. The stock traded during its last trading session with the total volume of 3,863,211 shares, as compared to its average volume of 4.37 million shares. Hecla Mining Company, together with its subsidiaries, discovers, acquires, and develops, produces, and markets precious and base metals worldwide. It offers unrefined gold and silver bullion bars to precious metals traders; and lead, zinc, and bulk concentrates to custom smelters.
For How Long HL will Fight for Profitability? Read This Trend Analysis report
AK Steel Holding Corporation (NYSE:AKS) remained among the day advancers and traded with volume of 3,776,558 shares in the last session, as compared to average volume of 6.65 million shares. In comparison with 52 week range of $2.76 - $6.09, it faced lowest price of $5.72 during the last trading session whereas its day highest price was $5.91. The company’s total market capitalization is $798.96 million, along with 136.34 million shares outstanding. AK Steel Holding Corporation produces flat-rolled carbon, stainless and electrical steel, and tubular products in the United States and internationally. The company produces flat-rolled carbon steels, including coated, cold-rolled, and hot-rolled carbon steel products.
For How Long AKS’s Gloss will Attract Investors? Find out via this report
Novavax, Inc. (NASDAQ:NVAX) showed 3,749,383 shares in volume during the last trading session, while the average trading volume remained 4.05 million shares. The stock kicked off its trading session at $4.26 and closed at $4.26 after mounting 0.71%. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Will NVAX Continue To Move Higher? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock traded during its last trading session with the total traded volume of 3,701,279 shares versus its average volume of 2.62 million shares. The company opened its trade at price of $4.72 and its closing price was $4.47 after losing -5.30% for the day. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Will MACK Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)